CT-2584 phospholipid composition modulator: CTIC began open-label U.S. efficacy testing

By WIR Staff | Dec 7, 1998 | 8:00 AM GMT

Cell Therapeutics Inc. (CTIC), Seattle, Wash.
Product:

Read the full 70 word article

How to gain access

Continue reading with a
two-week free trial.